Vignali DAA - Search Results

1

Inhibitory signaling sustains a distinct early memory CD8⁺ T cell precursor that is resistant to DNA damage.

Johnnidis JB, Muroyama Y, Ngiow SF, Chen Z, Manne S, Cai Z, Song S, Platt JM, Schenkel JM, Abdel-Hakeem M, Beltra JC, Greenplate AR, Ali MA, Nzingha K, Giles JR, Harly C, Attanasio J, Pauken KE, Bengsch B, Paley MA, Tomov VT, Kurachi M, Vignali DAA, Sharpe AH, Reiner SL, Bhandoola A, Johnson FB, Wherry EJ. Johnnidis JB, et al. Among authors: vignali daa. Sci Immunol. 2021 Jan 15;6(55):eabe3702. doi: 10.1126/sciimmunol.abe3702. Sci Immunol. 2021. PMID: 33452106 Free PMC article.

2

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA, Wherry EJ. Blackburn SD, et al. Nat Immunol. 2009 Jan;10(1):29-37. doi: 10.1038/ni.1679. Epub 2008 Nov 30. Nat Immunol. 2009. PMID: 19043418 Free PMC article.

3

Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells.

Grosso JF, Goldberg MV, Getnet D, Bruno TC, Yen HR, Pyle KJ, Hipkiss E, Vignali DA, Pardoll DM, Drake CG. Grosso JF, et al. J Immunol. 2009 Jun 1;182(11):6659-69. doi: 10.4049/jimmunol.0804211. J Immunol. 2009. PMID: 19454660 Free PMC article.

4

LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.

Lucas CL, Workman CJ, Beyaz S, LoCascio S, Zhao G, Vignali DA, Sykes M. Lucas CL, et al. Blood. 2011 May 19;117(20):5532-40. doi: 10.1182/blood-2010-11-318675. Epub 2011 Mar 21. Blood. 2011. PMID: 21422469 Free PMC article.

5

Inhibitory receptors as targets for cancer immunotherapy.

Turnis ME, Andrews LP, Vignali DA. Turnis ME, et al. Eur J Immunol. 2015 Jul;45(7):1892-905. doi: 10.1002/eji.201344413. Eur J Immunol. 2015. PMID: 26018646 Free PMC article. Review.

6

Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.

Dobbins J, Gagnon E, Godec J, Pyrdol J, Vignali DA, Sharpe AH, Wucherpfennig KW. Dobbins J, et al. Sci Signal. 2016 Jul 26;9(438):ra75. doi: 10.1126/scisignal.aaf0626. Sci Signal. 2016. PMID: 27460989 Free PMC article.

7

Cutting Edge: CD3 ITAM Diversity Is Required for Optimal TCR Signaling and Thymocyte Development.

Bettini ML, Chou PC, Guy CS, Lee T, Vignali KM, Vignali DAA. Bettini ML, et al. Among authors: vignali km, vignali daa. J Immunol. 2017 Sep 1;199(5):1555-1560. doi: 10.4049/jimmunol.1700069. Epub 2017 Jul 21. J Immunol. 2017. PMID: 28733484 Free PMC article.

8

LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes.

Zhang Q, Chikina M, Szymczak-Workman AL, Horne W, Kolls JK, Vignali KM, Normolle D, Bettini M, Workman CJ, Vignali DAA. Zhang Q, et al. Among authors: vignali km, vignali daa. Sci Immunol. 2017 Mar 31;2(9):eaah4569. doi: 10.1126/sciimmunol.aah4569. Sci Immunol. 2017. PMID: 28783703 Free PMC article.

9

Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.

Yano H, Andrews LP, Workman CJ, Vignali DAA. Yano H, et al. Among authors: vignali daa. Immunology. 2019 Jul;157(3):232-247. doi: 10.1111/imm.13067. Epub 2019 Jun 3. Immunology. 2019. PMID: 31087644 Free PMC article. Review.

10

Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor.

Ruffo E, Wu RC, Bruno TC, Workman CJ, Vignali DAA. Ruffo E, et al. Among authors: vignali daa. Semin Immunol. 2019 Apr;42:101305. doi: 10.1016/j.smim.2019.101305. Semin Immunol. 2019. PMID: 31604537 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page